Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

CAS No. :	73963-72-1
Formula :	C₂₀H₂₇N₅O₂
M.W :	369.46
SMILES Code :	O=C1NC2=C(C=C(OCCCCC3=NN=NN3C4CCCCC4)C=C2)CC1
Synonyms :	OPC 13013; OPC 21; Cilostazolum
MDL No. :	MFCD00866780
InChI Key :	RRGUKTPIGVIEKM-UHFFFAOYSA-N
Pubchem ID :	2754

GHS Pictogram:
Signal Word:	Danger
Hazard Statements:	H315-H319-H228
Precautionary Statements:	P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
Class:	4.1
UN#:	1325
Packing Group:	Ⅱ

Rat articular chondrocytes	30 μM	24 h	Cilostazol pre-treatment protected articular chondrocytes from oleate-induced lipoapoptosis by upregulating PKCK2 expression and reversed the oleate-induced decrease in FSP27 protein expression level.	Bone Res. 2018 Jul 6;6:20.
Rat primary vascular smooth muscle cells	10 μM	60 min	To investigate the effect of Cilostazol on BAY-induced VASP phosphorylation. Results showed that Cilostazol significantly reduced BAY-mediated VASP Ser239 phosphorylation.	Front Pharmacol. 2012 Feb 7;3:10.
Human peripheral blood mononuclear cell (PBMC) basophils	100 µM	30 min	To study the effect of PDE3 inhibitors on basophil degranulation, results showed that Cilostazol was able to impair basophil degranulation.	Front Pharmacol. 2020 May 1;11:470.
A7r5 rat vascular smooth muscle cells	100 and 200 μM	24 h	To investigate the effect of cilostazol on HG-induced dysfunction in A7r5 cells, the results showed that cilostazol significantly suppressed the expressions of RAGE, FAK, MMP-2, ICAM-1, and VCAM-1, and reversed cell proliferation, adhesion, and migration.	J Biomed Sci. 2019 Sep 6;26(1):68.

Mice	Tauopathy model	Intraperitoneal injection	3 mg/kg	Twice daily for 30 days	Cilostazol enhanced proteasome function via the cAMP/PKA pathway, reduced tau accumulation, and attenuated tauopathy and cognitive decline.	Transl Res. 2018 Mar;193:31-41
Mice	Tg2576 transgenic mice	Oral	0.01%	Daily, for 7-9 months	To investigate whether lower-dose cilostazol can decrease micro-hemorrhages and Aβ deposition in the brain of Tg2576 mice. Results showed that the CAA score was significantly lower in the cilostazol group compared to the control group at 21-23 months, indicating that lower-dose cilostazol can reduce the vascular amyloid burden.	Int J Mol Sci. 2020 Mar 26;21(7):2295
CD-1 mice	Stable closed femoral fracture model	Oral gavage	30 mg/kg	Daily administration for 2 or 5 weeks	Cilostazol accelerates fracture healing and induces bone formation in aged mice by stimulating angiogenesis and increasing the expression of PI3K and RUNX2.	Int J Mol Sci. 2024 Jan 6;25(2):755
Mice	High-fat diet-induced osteoarthritis model	Oral	30 mg·kg-1	Once daily for 10 weeks	Cilostazol significantly reduced high-fat diet-induced cartilage degeneration and increased the population of PKCK2-, STAMP2-, and FSP27-positive chondrocytes.	Bone Res. 2018 Jul 6;6:20.
Mice	ApoE null mice	Dietary supplementation	0.1%	16 weeks	Co-treatment of cilostazol with GbE significantly reduced atherosclerotic lesion area in ApoE null mice and decreased the expression of inflammatory cytokines and adhesion molecules.	Exp Mol Med. 2012 May 31;44(5):311-8

{[proInfo.proName]}

CAS No.: 73963-72-1

{[proInfo.proName]}

CAS No.: 73963-72-1

Product Citations

Alternative Products

Product Details of Cilostazol

Safety of Cilostazol

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT04753970	Cerebral Small Vessel Diseases... More >>\|Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy\|Cerebral Microbleeding\|Sporadic White Matter Disease Less <<	PHASE1\|PHASE2	RECRUITING	2025-06-26	Mayo Clinic Florida, Jacksonvi... More >>lle, Florida, 32224, United States Less <<
NCT00602173	Intermittent Claudication		COMPLETED	2025-05-03	CEDRA Clinical Research, LLC, ... More >>Austin, Texas, 78759, United States Less <<
NCT00048776	Raynaud's Disease	PHASE4	COMPLETED	2025-06-03	Advanced Medical Clinical Ther... More >>apeutics, Anchorage, Alaska, 99508, United States\|Advanced Medical Research Institute, Fresno, California, 93710, United States\|Madera Family Medical Group, Madera, California, 93637, United States\|Connecticut Children's Medical Center, Hartford, Connecticut, 06106, United States\|LaRabida Children's Hospital, Chicago, Illinois, 60649, United States\|Children's Hospital Boston, Boston, Massachusetts, 02115, United States\|St. Louis University Health Sciences Center, St. Louis, Missouri, 63104, United States\|Children's Hospital, Omaha, Nebraska, 68114, United States\|Asthma & Allergy Research Center, Newark, New Jersey, 07103, United States\|SUNY Downstate Medical Center, Brooklyn, New York, 11203, United States\|Children's Hospital of Buffalo, Buffalo, New York, 14222, United States\|Schneider Children's Hospital, New Hyde Park, New York, 11040, United States\|New York Medical College, Valhalla, New York, 10595, United States\|Jobst Vascular Center, Toledo, Ohio, 43606, United States\|Altoona Center for Clinical Research, Duncansville, Pennsylvania, 16635, United States\|The Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States\|Medical University of South Carolina, Charleston, South Carolina, 29425, United States\|Monarch Research Associates, Norfolk, Virginia, 23510, United States\|Children's Hospital and Regional Medical Center, Seattle, Washington, 98105, United States Less <<
NCT00048763	Raynaud's Disease	PHASE4	COMPLETED	2025-06-03	Advanced Medical Clinical Ther... More >>apeutics, Anchorage, Alaska, 99508, United States\|Advanced Medical Research Institute, Fresno, California, 93710, United States\|Madera Family Medical Group, Madera, California, 93637, United States\|Connecticut Children's Medical Center, Hartford, Connecticut, 06106, United States\|LaRabida Children's Hospital, Chicago, Illinois, 60649, United States\|Children's Hospital Boston, Boston, Massachusetts, 02115, United States\|St. Louis University Health Sciences Center, St. Louis, Missouri, 63104, United States\|Children's Hospital, Omaha, Nebraska, 68114, United States\|Asthma & Allergy Research Center, Newark, New Jersey, 07103, United States\|SUNY Downstate Medical Center, Brooklyn, New York, 11203, United States\|Children's Hospital of Buffalo, Buffalo, New York, 14222, United States\|Schneider Children's Hospital, New Hyde Park, New York, 11040, United States\|New York Medical College, Valhalla, New York, 10595, United States\|Jobst Vascular Center, Toledo, Ohio, 43606, United States\|The Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States\|Medical University of South Carolina, Charleston, South Carolina, 29425, United States\|Monarch Research Associates, Norfolk, Virginia, 23510, United States\|Children's Hospital and Regional Medical Center, Seattle, Washington, 98105, United States Less <<
NCT00431249	Hemodialysis Patients\|Peripher... More >>al Vascular Disease Less <<	PHASE4	COMPLETED	2025-04-08	-
NCT01915069	Contraception	PHASE2	COMPLETED	2025-08-14	University of Southern Califor... More >>nia Fertility Clinic, Los Angeles, California, 90017, United States Less <<
NCT00602407	Intermittent Claudication		COMPLETED	2025-03-04	CEDRA Clinical Research, LLC, ... More >>Austin, Texas, 78759, United States Less <<
NCT00404716	Acute Coronary Syndrome	PHASE4	COMPLETED	2025-02-07	-
NCT00773630	Intermittent Claudication	PHASE1	COMPLETED	2025-03-09	AAIPharma Deutschland GmbH & C... More >>o. KG, Neu-Ulm, 89231, Germany Less <<
NCT01455558	Healthy	PHASE1	COMPLETED	2025-09-09	Severance Hospital, Seoul, 120... More >>-752, Korea, Republic of Less <<
NCT02094469	Vasospastic Angina	PHASE3	COMPLETED	2025-01-16	Yangsan Busan University Hospi... More >>tal, Busan, 626-770, Korea, Republic of Less <<
NCT02374957	Peripheral Arterial Disease\|Cl... More >>audication (Finding) Less <<	PHASE4	TERMINATED	2017-06-30	Wake Forest Baptist Health, Wi... More >>nston-Salem, North Carolina, 27106, United States Less <<
NCT01076478	Polyneuropathy	PHASE4	COMPLETED	2025-11-09	University of Santo Tomas Hosp... More >>ital, Manila, Philippines Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed